| Literature DB >> 27400195 |
X Wang1, X Liu2,3, Y Zhang2,4, Z Wang2,5, G Zhu2,6, G Han2, G Chen2, C Hou2, T Wang4, N Ma7, B Shen2, Y Li2, H Xiao8, R Wang2.
Abstract
Interleukin (IL)-12 family cytokines play critical roles in autoimmune diseases. Our previous study has shown that IL-23p19 and Epstein-Barr virus-induced 3 (Ebi3) form a new IL-12 family heterodimer, IL-23p19/Ebi3, termed IL-39, and knock-down of p19 or Ebi3 reduced diseases by transferred GL7+ B cells in lupus-prone mice. In the present study, we explore further the possible effect of IL-39 on murine lupus. We found that IL-39 in vitro and in vivo induces differentiation and/or expansion of neutrophils. GL7+ B cells up-regulated neutrophils by secreting IL-39, whereas IL-39-deficient GL7+ B cells lost the capacity to up-regulate neutrophils in lupus-prone mice and homozygous CD19cre (CD19-deficient) mice. Finally, we found that IL-39-induced neutrophils had a positive feedback on IL-39 expression in activated B cells by secreting B cell activation factor (BAFF). Taken together, our results suggest that IL-39 induces differentiation and/or expansion of neutrophils in lupus-prone mice.Entities:
Keywords: BAFF; IL-39; autoimmune diseases; lupus; neutrophils
Mesh:
Substances:
Year: 2016 PMID: 27400195 PMCID: PMC5054574 DOI: 10.1111/cei.12840
Source DB: PubMed Journal: Clin Exp Immunol ISSN: 0009-9104 Impact factor: 4.330